Conjunctivitis Drugs Market SWOT Analysis, Dynamics, Drivers, Key Indicators and Forecast to 2022-2030

 

Conjunctivitis Drugs Market Highlights

Conjunctivitis is an eye condition characterized by inflammation of external white part and eyelids. Although this medical condition is caused due to various factors but bacterial and virus are most prominent causes accounting for more than 50% cases of conjunctivitis.  The market for conjunctivitis drugs is facing stagnant growth in developed regions. Also, a number of patents which have expired such as Moxeza, Besivance, Vigamox, and Zymaxid have dampened the market growth. The market is further characterized by easy entry but high competition which has resulted into greater penetration by generics. The best strategy for firms is market development especially the Asian Pacific market which is poised to lead the growth of the global market soon. The market is further dampened by the better efficacy and broad spectrum of anti-bacterial drugs led by quinolones. Quinolones especially Fluoroquinolones has a dominant market share for conjunctivitis. The research pipeline is somewhat weak with many other classes of antibiotics exhibiting greater toxicity. Thus, quinolones have immensely raised the acceptable bar for newer drugs.

 

The market is chiefly driven by unmet needs in developing regions along with greater awareness and rising incomes in these regions. These reasons along with contagious nature of the disease along with rise of drug resistance also driving the market of other antibiotics which has greater toxicity such as macrolide class. Off label drug use is also one of the market drivers due to cheap generics and greater availability of these drugs.

The global conjunctivitis drugs market has been evaluated to be growing and it is expected that it will touch high growth figures in future. Conjunctivitis Drugs Market size is expected to reach USD 4.45 billion at a CAGR 3.30% during the forecast period 2022-2030. Market development and diversification into Asian Pacific market seems to have better strategy for the current situation.

Key Players:

 

The global conjunctivitis drugs market players are: Akorn Pharmaceuticals, Alcon/ Novartis AG, Allergan Plc, Bausch & Lomb, Valeant Pharmaceuticals, Merck & Co. Inc., Actavis Plc., Pfizer Inc. and others.

 

Regional Analysis:

 

Depending on geographic region, conjunctivitis drugs market is segmented into four key regions: America, Europe, Asia Pacific, and Middle East & Africa. Globally, America is the largest market for conjunctivitis drugs followed by Europe. However, the developed regions market is stagnant, and any future growth will be led by the developing regions especially Asia pacific region. The unmet drug needs and greater awareness are prime driver of the conjunctivitis drugs market. Greater exposure to allergens and infective agents is also driving the market’s growth.

 

Segmentation:

 

Global conjunctivitis drugs market report has been segmented on the basis of conjunctivitis type which comprises of viral, bacterial, allergic and others types of conjunctivitis.

On the basis of drug class, market is segmented into antibiotics (quinolones, aminoglycosides, macrolides and others), mast cell stabilizers, steroids and others.

On the basis of route of administration, market is segmented into topical, oral and intra-vitreal.

On the basis of end users, market is segmented into hospitals and self-administered.

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Medical Implants Market Growth Drivers, Investment Opportunity, and Product Developments 2030 |MRFR

  Genetic Engineering Market Overview Genetic engineering or genetic modification is the manipulation of genes in an organism for enhancing its abilities. Genetic engineering is generally used by biotechnology and pharmaceutical companies, and clinical research organizations and is extensively used to treat cancer and other infectious disease. The genetic engineering market is expected to reach USD 5,811 Million by 2030 at 24.20% CAGR during the forecast period 2022-2030, asserts Market Research Future (MRFR). Drivers and Constraints Impacting the Market Technologies such as ZNF, CRISPR/Cas9, and TALEN are extensively used in gene therapy for various terminal illness and genetic disorders.   Such emerging technologies and innovations are likely to stimulate the market growth during the forecast period. Moreover, with the widespread use of genetic engineering in developed countries, application in the medicine industry, and special attention towards stem cells are pre...
Read more

Veterinary CBD Market Growth, size & share, Analysis, prediction research report and forecast to 2020-2027

  This impressive CAGR is possible due to the increasing number of household pets, the rising demand for humane practices in livestock management, and the easing of restrictions governing the use of CBD products to treat various ailments. The  Global Veterinary CBD Market   is poised to register a  CAGR of 129.97%  during the forecast period. The market for global veterinary CBD products is already very diverse with multiple channels of sale. Get Sample Report @ https://www.marketresearchfuture.com/sample_request/8138 SEGMENTATION ·          By Source ·          By Product ·          By Distribution Channel ·          By Region Regional Analysis The global veterinary CBD market is currently concentrated in North America but there is significant untapped potential in other regions due...
Read more

Smart Biosensors Market Type, Product, Key Players, Application and Growth Forecast to 2030 | MRFR

  Smart Biosensors Market Highlights Smart biosensors are medical devices used for chemical and biological analysis of a human body or any biological substance. Smart biosensors are advance and more effective than other traditional sensors. The increasing prevalence of diabetes in emerging economies, demand for advanced monitoring systems, and increasing awareness about advance biosensors are the major factors driving the growth of the global smart biosensors market. According to the International Diabetic Federation, about 415 million people across the globe were reported to have diabetes in 2015, and this number is expected to reach 642 million by 2040. It also stated that 98.4 million and 65.1 million diabetic population lived in China and India respectively. The Smart Biosensors market is anticipated to reach USD 23819.88 Million by 2030 at 6.90% CAGR during the forecast period 2022-2030. The rising cost of biosensors and unfavourable reimbursement polici...
Read more